Human aging is associated with loss of tissue homeostasis and a greatly elevated risk of debilitating disease, with associated costs in terms of diminished quality of life for the individual and financial burdens on health-care providers. Any advances that hold out the realistic prospect of tackling age-related morbidity are therefore to be welcomed. The recent report by Jeskelioff et al. published in 2010 that telomerase reactivation in adult male mice not only halts but actually reverse significant tissue pathologies provides a long-awaited proof of principle that it is possible to rejuvenate aged tissues. This review assesses the impact of this new work and considers possible problems and potential benefits of telomerase activation as a therapy to tackle the morbidities associated with human aging.
FloresI, CanelaA, VeraE, TejeraA, CotsarelisG, BlascoMA. The longest telomeres: A general signature of adult stem cell compartments. Genes Dev, 2008; 22:654–667.
9.
FloresI, BlascoMA. The role of telomeres and telomerase in stem cell aging. FEBS Lett, 2010; 584:3826–3830.
10.
WyllieFS, JonesCJ, SkinnerJW, HaughtonMF, WallisC, Wynford-ThomasD, FaragherRG, KiplingD. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet, 2000; 24:16–17.
11.
MetzgerD, CliffordJ, ChibaH, ChambonP. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA, 1995; 92:6991–6995.
12.
WongLS, OeseburgH, de BoerRA, van GilstWH, van VeldhuisenDJ, van der HarstP. Telomere biology in cardiovascular disease: The TERC−/− mouse as a model for heart failure and ageing. Cardiovasc Res, 2009; 81:244–252.
13.
LuX. Tied up in loops: Positive and negative autoregulation of p53. Cold Spring Harb Perspect Biol, 2010; 2:a000984.
14.
PassosJF, NelsonG, WangC, RichterT, SimillionC, ProctorCJ, MiwaS, OlijslagersS, HallinanJ, WipatA, SaretzkiG, RudolphKL, KirkwoodTB, von ZglinickiT. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol, 2010; 6:347.
15.
YamanakaS, BlauHM. Nuclear reprogramming to a pluripotent state by three approaches. Nature, 2010; 465:704–712.
16.
YehezkelS, Rebibo-SabbahA, SegevY, TzukermanM, ShakedR, HuberI, GepsteinL, SkoreckiK, SeligS. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics, 2011; 6:63–75.
17.
FloresI, CayuelaML, BlascoMA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science, 2005; 309:1253–1256.
18.
GiangrecoA, QinM, PintarJE, WattFM. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell, 2008; 7:250–259.
19.
RossiDJ, BryderD, SeitaJ, NussenzweigA, HoeijmakersJ, WeissmanIL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature, 2007; 447:725–729.
HarrisonDE, StrongR, SharpZD, NelsonJF, AstleCM, FlurkeyK, NadonNL, WilkinsonJE, FrenkelK, CarterCS, PahorM, JavorsMA, FernandezE, MillerRA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 2009; 460:392–395.
26.
NakamuraT, ImaiY, MatsumotoT, SatoS, TakeuchiK, IgarashiK, HaradaY, AzumaY, KrustA, YamamotoY, NishinaH, TakedaS, TakayanagiH, MetzgerD, KannoJ, TakaokaK, MartinTJ, ChambonP, KatoS. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell, 2007; 130:811–823.
27.
BroulikPD. Tamoxifen prevents bone loss in ovariectomized mice. Endocr Regul, 1991; 25:217–219.
28.
DumitriuD, RappPR, McEwenBS, MorrisonJH. Estrogen and the aging brain: An elixir for the weary cortical network. Ann NY Acad Sci, 2010; 1204:104–112.
29.
LuoW, SharifTR, HoughtonPJ, SharifM. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Cell Growth Differ, 1997; 8:1225–1240.
30.
CampisiJ. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol, 2001; 11:S27–S31.
31.
TianX, ChenB, LiuX. Telomere and telomerase as targets for cancer therapy. Appl Biochem Biotechnol, 2010; 160:1460–1472.
HultmanCM, SandinS, LevineSZ, LichtensteinP, ReichenbergA. Advancing paternal age and risk of autism: New evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry, 2010Nov30epub ahead of print.
34.
PerrinMC, BrownAS, MalaspinaD. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr Bull, 2007; 33:1270–1273.
35.
SmithRG, KemberRL, MillJ, FernandesC, SchalkwykLC, BuxbaumJD, ReichenbergA. Advancing paternal age is associated with deficits in social and exploratory behaviors in the offspring: A mouse model. PLoS One, 2009; 4:e8456.
CaladoRT. Telomeres and marrow failure. Hematology Am Soc Hematol Educ Program, 2009; 338–343.
39.
LiangJ, YagasakiH, KamachiY, HamaA, MatsumotoK, KatoK, KudoK, KojimaS. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. Haematologica, 2006; 91:656–658.
40.
CaladoRT, RegalJA, KleinerDE, SchrumpDS, PetersonNR, PonsV, ChanockSJ, LansdorpPM, YoungNS. A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One, 2009; 4:e7926.
BesslerM, WilsonDB, MasonPJ. Dyskeratosis congenita. FEBS Lett, 2010; 584:3831–3838.
43.
Jourdan Le SauxC, DavyCP, BramptonC, PirotZ, TesslerR, HarleyC, AllsoppR. Telomerase activator prevents the development of lung fibrosis in bleomycin mouse model. Am J Respir Crit Care Med, 2010; 181:A1059.
44.
HarleyCB, LiuW, BlascoM, VeraE, AndrewsWH, BriggsLA, RaffaeleJM. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res, 2010on line ahead of print10.1089/rej.2010.1085.
45.
FauceSR, JamiesonBD, ChinAC, MitsuyasuRT, ParishST, NgHL, KitchenCM, YangOO, HarleyCB, EffrosRB. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol, 2008; 181:7400–7406.
46.
EpelES, BlackburnEH, LinJ, DhabharFS, AdlerNE, MorrowJD, CawthonRM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A, 2004; 101:17312–17315.
47.
AtzmonG, RinconM, RabizadehP, BarzilaiN. Biological evidence for inheritance of exceptional longevity. Mech Ageing Dev, 2005; 126:341–345.
